VolitionRX Ltd
AMEX:VNRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VolitionRX Ltd
AMEX:VNRX
|
US |
|
Aura Energy Ltd
OTC:AUEEF
|
AU |
|
thyssenkrupp AG
F:TKA1
|
DE |
|
Daetwyler Holding AG
SIX:DAE
|
CH |
|
B
|
Boston Beer Company Inc
F:BBEA
|
US |
|
C
|
Corporate Office Properties Trust
F:WX7
|
US |
|
P
|
Pacira Biosciences Inc
XBER:82P
|
US |
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
|
F
|
FirstGroup PLC
F:FGR
|
UK |
|
S
|
Sinopharm Group Co Ltd
SWB:X2S
|
CN |
|
E
|
Equinor ASA
DUS:DNQ
|
NO |
|
P
|
Pfizer Inc
BMV:PFE
|
US |
Wall St Price Targets
VNRX Price Targets Summary
VolitionRX Ltd
According to Wall Street analysts, the average 1-year price target for VNRX is 1.73 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VNRX's stock price target?
Price Target
1.73
USD
According to Wall Street analysts, the average 1-year price target for VNRX is 1.73 USD with a low forecast of 1.01 USD and a high forecast of 3.15 USD.
What is the Revenue forecast for VolitionRX Ltd?
Projected CAGR
97%
Over the last 13 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 8 years is 97%.